A double blind, randomized, placebo controlled study to evaluate the effect of ProSolutionTM pills in enhancing sexual function of men with erectile dysfunction

eading Edge Marketing, PO Box CR-56766, Suite 1210Nassau Bahamas0 个研究点目标入组 84 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Males aged 25-50 years, involved in a stable heterosexual relationship of >6 months
•Subjects with Erectile Dysfunction (ED) since at least 3 months
•IIEF-A (Erectile Function) score in the range of 11 ? 23
•IIEF-B score (Other than Erectile Function) in the range of 21 - 35

•Significant cardiovascular or any other co-morbidities
•Use of sildenafil or any other phosphodiesterase type inhibitor within previous 6 weeks
•Current use of any other therapy for treatment of ED
•Subjects with Diabetes
•Subjects with Hypertension
•Subjects taking medications known to cause ED
•Subjects with major psychiatric disorders
•Subjects with Low Testosterone Levels (<200 ng/dl)
•Subjects with history of spinal cord injury or a radical prostatectomy or radical pelvic surgery.
•Subjects with anatomical deformity of the penis which has a severe effect on sexual functioning
•Subjects with HIV or AIDS or any other sexually transmitted disease
•Subjects with Hyperprolactinemia

发起方

eading Edge Marketing, PO Box CR-56766, Suite 1210Nassau Bahamas